(BHE) Benchmark Electronics - Overview
Sector: Technology | Industry: Electronic Components | Exchange: NYSE (USA) | Market Cap: 3.122m USD | Total Return: 132.4% in 12m
Industry Rotation: -1.3
Avg Turnover: 34.8M
EPS Trend: 52.0%
Qual. Beats: 3
Rev. Trend: -70.5%
Qual. Beats: 0
Warnings
P/E ratio 92.6
Tailwinds
Supp Ema8, Leader, Tailwind, Confidence
Benchmark Electronics, Inc. (BHE) provides comprehensive product design, engineering, and manufacturing services across the Americas, Asia, and Europe. The company specializes in electronics manufacturing services (EMS), including printed circuit board assembly, precision metal machining, and complex system integration. Its operations span the entire product lifecycle, from initial prototyping and testing to aftermarket repair and supply chain management.
The company operates within the high-mix, low-volume segment of the EMS industry, focusing on regulated markets such as aerospace, defense, medical, and semiconductor capital equipment. Unlike consumer electronics manufacturers, firms in this sector prioritize rigorous reliability testing and environmental stress screening to meet the stringent safety and performance standards of industrial and mission-critical applications.
Investors can evaluate the company’s competitive positioning and valuation metrics on ValueRay. Benchmark Electronics manages its global business development primarily through a direct sales force to maintain long-term relationships with original equipment manufacturers (OEMs).
- Semiconductor capital equipment cycle recovery drives high-margin precision machining revenue
- Aerospace and defense spending increases fuel long-term engineering services backlog
- Shift toward medical technology and industrial automation improves overall gross margins
- Inventory normalization across communications end markets stabilizes quarterly revenue growth
- Global manufacturing footprint exposure creates sensitivity to regional labor cost inflation
| Net Income: 34.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.45 > 1.0 |
| NWC/Revenue: 29.24% < 20% (prev 33.26%; Δ -4.02% < -1%) |
| CFO/TA 0.07 > 3% & CFO 139.5m > Net Income 34.2m |
| Net Debt (-20.6m) to EBITDA (157.0m): -0.13 < 3 |
| Current Ratio: 2.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.3m) vs 12m ago -0.90% < -2% |
| Gross Margin: 10.10% > 18% (prev 0.10%; Δ 1.00k% > 0.5%) |
| Asset Turnover: 127.8% > 50% (prev 122.3%; Δ 5.50% > 0%) |
| Interest Coverage Ratio: 6.00 > 6 (EBITDA TTM 157.0m / Interest Expense TTM 18.5m) |
| A: 0.38 (Total Current Assets 1.46b - Total Current Liabilities 669.2m) / Total Assets 2.10b |
| B: 0.27 (Retained Earnings 570.5m / Total Assets 2.10b) |
| C: 0.05 (EBIT TTM 111.1m / Avg Total Assets 2.12b) |
| D: 0.56 (Book Value of Equity 563.4m / Total Liabilities 999.7m) |
| Altman-Z'' Score: 4.31 = AA |
| DSRI: 1.00 (Receivables 566.8m/546.1m, Revenue 2.70b/2.61b) |
| GMI: 1.00 (GM 10.10% / 10.09%) |
| AQI: 1.03 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.04 (Revenue 2.70b / 2.61b) |
| TATA: -0.05 (NI 34.2m - CFO 139.5m) / TA 2.10b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
Over the past week, the price has changed by -0.67%, over one month by +36.34%, over three months by +46.76% and over the past year by +132.37%.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 78 | -8.2% |
P/E Forward = 14.1443
P/S = 1.1545
P/B = 2.7979
P/EG = 1.328
Revenue TTM = 2.70b USD
EBIT TTM = 111.1m USD
EBITDA TTM = 157.0m USD
Long Term Debt = 201.0m USD (from longTermDebt, last quarter)
Short Term Debt = 3.75m USD (from shortTermDebt, last quarter)
Debt = 304.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -20.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.10b USD (3.12b + Debt 304.3m - CCE 324.9m)
Interest Coverage Ratio = 6.00 (Ebit TTM 111.1m / Interest Expense TTM 18.5m)
EV/FCF = 35.72x (Enterprise Value 3.10b / FCF TTM 86.8m)
FCF Yield = 2.80% (FCF TTM 86.8m / Enterprise Value 3.10b)
FCF Margin = 3.21% (FCF TTM 86.8m / Revenue TTM 2.70b)
Net Margin = 1.27% (Net Income TTM 34.2m / Revenue TTM 2.70b)
Gross Margin = 10.10% ((Revenue TTM 2.70b - Cost of Revenue TTM 2.43b) / Revenue TTM)
Gross Margin QoQ = 10.24% (prev 10.40%)
Tobins Q-Ratio = 1.48 (Enterprise Value 3.10b / Total Assets 2.10b)
Interest Expense / Debt = 1.20% (Interest Expense 3.65m / Debt 304.3m)
Taxrate = 29.31% (5.40m / 18.4m)
NOPAT = 78.5m (EBIT 111.1m * (1 - 29.31%))
Current Ratio = 2.18 (Total Current Assets 1.46b / Total Current Liabilities 669.2m)
Debt / Equity = 0.28 (Debt 304.3m / totalStockholderEquity, last quarter 1.10b)
Debt / EBITDA = -0.13 (Net Debt -20.6m / EBITDA 157.0m)
Debt / FCF = -0.24 (Net Debt -20.6m / FCF TTM 86.8m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.62% (Net Income 34.2m / Total Assets 2.10b)
RoE = 3.10% (Net Income TTM 34.2m / Total Stockholder Equity 1.10b)
RoCE = 8.52% (EBIT 111.1m / Capital Employed (Equity 1.10b + L.T.Debt 201.0m))
RoIC = 5.98% (NOPAT 78.5m / Invested Capital 1.31b)
WACC = 9.87% (E(3.12b)/V(3.43b) * Re(10.75%) + D(304.3m)/V(3.43b) * Rd(1.20%) * (1-Tc(0.29)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.67 | Cagr: 0.39%
[DCF] Terminal Value 62.67% ; FCFF base≈108.4m ; Y1≈71.2m ; Y5≈32.5m
[DCF] Fair Price = 14.13 (EV 486.3m - Net Debt -20.6m = Equity 506.8m / Shares 35.9m; r=9.87% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 52.05 | EPS CAGR: 4.04% | SUE: 1.03 | # QB: 3
Revenue Correlation: -70.53 | Revenue CAGR: -1.91% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.69 | Chg30d=+15.74% | Revisions=+43% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.72 | Chg30d=+8.05% | Revisions=+43% | Analysts=3
EPS current Year (2026-12-31): EPS=2.75 | Chg30d=+7.98% | Revisions=+43% | GrowthEPS=+14.6% | GrowthRev=+9.3%
EPS next Year (2027-12-31): EPS=3.10 | Chg30d=+8.51% | Revisions=+43% | GrowthEPS=+12.8% | GrowthRev=+6.5%
[Analyst] Revisions Ratio: +43%